Celiac disease

Celiac disease

MDY2U2 - GI/OB

MDY2U2 - GI/OB

Herpes simplex virus
Candida
Aphthous ulcers
Lichen planus
Oral cancer
Anatomy of the oral cavity
Oral candidiasis
Blood and nerve supply of the oral cavity
Anatomy and physiology of the teeth
Development of the teeth
Cleidocranial dysplasia
Bruxism
Dental abscess
Gingivitis and periodontitis
Dental caries disease
Tooth decay and cavities
Eruption of primary and permanent dentitions
Ludwig angina
Taste and the tongue
Sialadenitis
Anatomy of the salivary glands
Sjogren syndrome: Clinical
Sjogren syndrome: Pathology review
Chewing and swallowing
Gastroesophageal reflux disease (GERD)
Gastroesophageal reflux disease (GERD): Clinical
Scleroderma
Pyloric stenosis
Pediatric vomiting: Clinical
Meckel diverticulum
Gastric motility
Esophageal motility
Enteric nervous system
Intussusception
Volvulus
Hirschsprung disease
Gastric cancer
Stomach histology
Barrett esophagus
Esophageal disorders: Clinical
Plummer-Vinson syndrome
Eosinophilic esophagitis (NORD)
Achalasia
Diffuse esophageal spasm
Gastritis
Diarrhea: Clinical
Clostridium difficile (Pseudomembranous colitis)
Inflammatory bowel disease: Clinical
Hernias: Clinical
Abdominal hernias
Appendicitis: Clinical
Appendicitis
Colorectal polyps and cancer: Pathology review
Colorectal polyps
Colorectal cancer
Gallstones
Gallbladder disorders: Pathology review
Acute pancreatitis
Jaundice: Clinical
Celiac disease
Viral hepatitis
Non-alcoholic fatty liver disease
Alcohol-associated liver disease
Anemia of chronic disease
Wilson disease
Cirrhosis
Hemochromatosis
Portal hypertension
Pharmacokinetics: Drug metabolism
Acetaminophen (Paracetamol)
Primary biliary cholangitis
Primary sclerosing cholangitis
Hepatocellular carcinoma
Hypertriglyceridemia
Familial hypercholesterolemia
Atherosclerosis and arteriosclerosis: Pathology review
Hunger and satiety
Hypercholesterolemia: Clinical
Diabetes mellitus
Diabetes mellitus: Pathology review
Diabetes mellitus: Clinical
Insulin
Thyroid nodules and thyroid cancer: Clinical
Hypothyroidism
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism: Clinical
Hyperthyroidism
Hashimoto thyroiditis
Riedel thyroiditis
Thyroid storm
Hypothyroidism medications
Hyperthyroidism medications
Constitutional growth delay
Growth hormone deficiency
Amenorrhea
Puberty and Tanner staging
Premature ovarian failure
Polycystic ovary syndrome
Pituitary adenomas and pituitary hyperfunction: Clinical
Menopause
Anatomy and physiology of the female reproductive system
Menstrual cycle
Oxytocin and prolactin
Thyroid hormones
Pregnancy
Fetal circulation
Fetal alcohol syndrome
Preeclampsia & eclampsia
Endometritis
Abnormal uterine bleeding: Clinical
Vulvovaginitis: Clinical
Routine prenatal care: Clinical
Stages of labor
Vitamin D
Osteomalacia and rickets
Parathyroid conditions and calcium imbalance: Clinical
Hyperparathyroidism
Parathyroid hormone
Hypoparathyroidism
Hypocalcemia
Calcitonin
Osteoporosis
Bone remodeling and repair
Benign breast conditions: Pathology review
Breast cancer: Pathology review
Human papillomavirus
Cervical cancer
Cervical cancer: Clinical
Cervical cancer: Pathology review
Sexually transmitted infections: Vaginitis and cervicitis: Pathology review

Flashcards

Celiac disease

0 of 8 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 3 complete

Start
A 15-year-old female comes to her primary care physician for evaluation of abdominal pain, bloating, and diarrhea. The symptoms began several months ago. She describes the diarrhea as bulky and foul-smelling. Over the past week, the patient also developed a pruritic rash on the bilateral forearms. Past medical history is significant for type I diabetes mellitus, which is well managed with insulin. She recently traveled to Mexico and ate food from local street vendors. Vital signs are within normal limits. Physical examination reveals conjunctival pallor, as well as multiple tense, grouped blisters on her forearms and excoriations. The abdomen is mildly tender to palpation. Laboratory testing reveals positive anti-tissue transglutaminase antibodies. If this patient’s condition is untreated, which of the following complications is she at greatest risk of developing?

Transcript

Watch video only

It’s becoming more and more common to see things like “gluten-free pizza” or “gluten-free buns” and other gluten-free items at restaurants, grocery stores, or other food-based businesses. This is partly because there’s this increasing recognition, awareness, and diagnosis of a disease called Celiac Disease, in the past called celiac sprue. As many as 1 in 100 people have Celiac disease although many remain undiagnosed.

Now, Celiac disease is currently understood as an immune system-mediated disorder, where the gluten in food triggers the body’s immune cells to attack the cells in the small intestine as well as produce auto-antibodies against tissue transglutaminase also found in the small intestine as well as other tissues like the heart or the liver.

Gluten’s found in common wheats and grains, including wheat, rye and barley. If we take a look at wheat, you’ve got your individual wheat kernels, and then inside each kernel there is the endosperm, which has a bunch of nutrients for the seed’s embryo, mostly protein and starch, and some vitamins. The type of protein here is gluten, the main culprit in celiac disease.

Well, really the main culprit behind celiac disease is gliadin, an umbrella term given to a group of gluten peptides that share a 33 amino-acid sequence which triggers an immune response. So, if somebody with celiac disease eats a wheat-based pizza, it’s broken down in the stomach into gluten peptides ...and a whole lot of other stuff.

That other stuff is no challenge for digestion - gluten peptides, like the gliadin in wheat, however, are high in proline and glutamine, two amino acids which make it a tough little bugger to digest.

So when the undigested gluten proteins, like gliadin, get to the small intestine, they meet the intestinal mucosa, which is lined with a layer of intestinal epithelial cells. Gluten proteins can then get across the gut epithelial cells, either between them, or through the cell, from the apical to the basolateral membrane, and get to the lamina propria, which is a thin layer that lines the gut wall.

Once there, an enzyme called tissue transglutaminase, or tTG, cuts off of an amide group from the protein. Deamidated gluten proteins are then eaten up by macrophages and served up on its MHC class II molecules.

Remember, macrophages are in the gut and are always doing a bit of “gut sampling” where they grab proteins (which a lot of times are from foods that we’ve eaten) and show them to the immune cells.

MHC stands for Major Histocompatibility Complex and is that name of the “serving platter” for the stuff that is served up. It’s a normal way to make sure that there are no pathogenic bacteria lurking in the gut.

Now there are a ton of different types of MHC class II “serving platters” and these serving platters are encoded by genes called human leukocyte antigen genes, or HLA genes. These genes determine what things the MHC class II molecules “serve up”, so, for example, HLA-DR encodes for an MHC that “serves up” something different than the one HLA-DQ encodes for.

Researchers have noticed that patients with celiac disease typically have specific HLA genes, specifically HLA-DQ2 and HLA-DQ8, which code for MHC serving platters that allow deamidated gliadin to bind tightly.

And when deamidated gliadin is tightly bound to these specific MHC serving platters, that’s when the immune system kicks in. The macrophage throws it up top and is like “hey, uh, guys? What do you think about this molecule…?” and T helper cells, also known as CD4+ T-cells, from the immune system that recognize the gliadin zoom over and are like “Yep, I’ll take it from here”, and they release inflammatory cytokines like interferon gamma and tumor necrosis factor, which are molecules that initiate inflammation directly damaging and destroying epithelial cells in the villi of the small intestine in the process.

Not only that though, the helper T cell stimulates B cells to start pumpin’ out IgA antibodies against gliadin and the tissue transglutaminase enzyme. Of these, anti-tissue transglutaminase antibodies play a role in some of the non-digestive complications of celiac disease.

Anti-gliadin antibodies, on the other hand, don’t cause any damage; they are, however, helpful in making a diagnosis. Finally, the helper T cells also recruit killer CD8+ T cells, which is when things get nasty. Killer T cells are drawn to and destroy cells undergoing inflammation.

So, in short, as patients eat gluten, the immune system is stimulated and epithelial cells are destroyed. It’s possible that the destruction of these cells lets more gliadin across the epithelium, since they’re not bunched together as tightly as they were before.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw-Hill Education / Medical (2019)
  5. "Ulcerative colitis" The Lancet (2017)
  6. "ACG Clinical Guideline: Ulcerative Colitis in Adults" American Journal of Gastroenterology (2019)
  7. "Colonic Sulfide in Pathogenesis and Treatment of Ulcerative Colitis" Digestive Diseases and Sciences (1997)